Communiqués QScreen AI Inc.

Actions

QAI

CA7469601032

Machines et équipements industriels

Marché Fermé - Canadian Securities Exchange 17:57:04 20/08/2026			Varia. 5j.	Varia. 1 janv.
0,0300 ^CAD	+20,00%		0,00%	-57,14%

20/07	QScreen AI Inc. achève son architecture de dépistage multiniveau et démontre sa capacité d'examen par escalade	CI
14/07	QScreen AI obtient un deuxième brevet américain pour sa méthode de détection des facultés affaiblies	MT

Communiqués

20/07	QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability	NE
14/07	QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware	NE
26/06	QScreen AI Announces Adoption of Semi-Annual Reporting	NE
25/06	QScreen AI Announces Close of First Tranche of Private Placement	NE
01/06	QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones	NE
19/05	QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration	NE
06/05	QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time	NE
04/05	QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios	NE
29/04	QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets	NE
27/04	QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths	NE
26/02	QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America	NE
23/02	QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico	NE
17/02	QScreen AI Advances Quantum-Inspired Optimization with U.S. Patent Filing; Gains National Spotlight on CBC	NE
09/02	Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health	NE
27/01	Predictmedix AI Rebrands as QScreen AI Inc., (QAI) Harnessing Quantum-AI Synergy for Health Screening	NE
26/01	CSE Bulletin: Name and Symbol Change - Predictmedix AI Inc. (PMED)	NE
15/01	Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships	NE
12/01	Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare	NE
17/12	Predictmedix AI Inc - 2025 Year End Corporate Update	NE
05/12	Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement	NE
17/11	Predictmedix AI Announces Closing of $460,150 First Tranche	NE
20/10/25	Predictmedix AI Announces Non-Brokered Private Placement	NE
13/10/25	Predictmedix AI : to Present at the 25th MK Investment Conference in Munich, Germany	PU
13/10/25	Predictmedix AI : Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader	PU
01/10/25	Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform	NE